2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Microscopic Polyangiitis.
Journal
Arthritis & rheumatology (Hoboken, N.J.)
ISSN: 2326-5205
Titre abrégé: Arthritis Rheumatol
Pays: United States
ID NLM: 101623795
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
revised:
29
03
2021
received:
28
02
2020
accepted:
21
09
2021
pubmed:
3
2
2022
medline:
15
3
2022
entrez:
2
2
2022
Statut:
ppublish
Résumé
To develop and validate classification criteria for microscopic polyangiitis (MPA). Patients with vasculitis or comparator diseases were recruited into an international cohort. The study proceeded in 5 phases: 1) identification of candidate items using consensus methodology, 2) prospective collection of candidate items present at the time of diagnosis, 3) data-driven reduction of the number of candidate items, 4) expert panel review of cases to define the reference diagnosis, and 5) derivation of a points-based risk score for disease classification in a development set using least absolute shrinkage and selection operator logistic regression, with subsequent validation of performance characteristics in an independent set of cases and comparators. The development set for MPA consisted of 149 cases of MPA and 408 comparators. The validation set consisted of an additional 142 cases of MPA and 414 comparators. From 91 candidate items, regression analysis identified 10 items for MPA, 6 of which were retained. The final criteria and their weights were as follows: perinuclear antineutrophil cytoplasmic antibody (ANCA) or anti-myeloperoxidase-ANCA positivity (+6), pauci-immune glomerulonephritis (+3), lung fibrosis or interstitial lung disease (+3), sino-nasal symptoms or signs (-3), cytoplasmic ANCA or anti-proteinase 3 ANCA positivity (-1), and eosinophil count ≥1 × 10 The 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for MPA are now validated for use in clinical research.
Substances chimiques
Antibodies, Antineutrophil Cytoplasmic
0
Types de publication
Journal Article
Practice Guideline
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
400-406Investigateurs
Paul Gatenby
(P)
Catherine Hill
(C)
Dwarakanathan Ranganathan
(D)
Andreas Kronbichler
(A)
Daniel Blockmans
(D)
Lillian Barra
(L)
Simon Carette
(S)
Christian Pagnoux
(C)
Navjot Dhindsa
(N)
Aurore Fifi-Mah
(A)
Nader Khalidi
(N)
Patrick Liang
(P)
Nataliya Milman
(N)
Christian Pineau
(C)
Xinping Tian
(X)
Guochun Wang
(G)
Tian Wang
(T)
Ming-Hui Zhao
(MH)
Vladimir Tesar
(V)
Bo Baslund
(B)
Nevin Hammam
(N)
Amira Shahin
(A)
Laura Pirila
(L)
Jukka Putaala
(J)
Bernhard Hellmich
(B)
Jörg Henes
(J)
Peter Lamprecht
(P)
Thomas Neumann
(T)
Wolfgang Schmidt
(W)
Cord Sunderkoetter
(C)
Zoltan Szekanecz
(Z)
Debashish Danda
(D)
Siddharth Das
(S)
Rajiva Gupta
(R)
Liza Rajasekhar
(L)
Aman Sharma
(A)
Shrikant Wagh
(S)
Michael Clarkson
(M)
Eamonn Molloy
(E)
Carlo Salvarani
(C)
Franco Schiavon
(F)
Enrico Tombetti
(E)
Augusto Vaglio
(A)
Koichi Amano
(K)
Yoshihiro Arimura
(Y)
Hiroaki Dobashi
(H)
Shouichi Fujimoto
(S)
Masayoshi Harigai
(M)
Fumio Hirano
(F)
Junichi Hirahashi
(J)
Sakae Honma
(S)
Tamihiro Kawakami
(T)
Shigeto Kobayashi
(S)
Hajime Kono
(H)
Hirofumi Makino
(H)
Kazuo Matsui
(K)
Eri Muso
(E)
Kazuo Suzuki
(K)
Kei Ikeda
(K)
Tsutomu Takeuchi
(T)
Tatsuo Tsukamoto
(T)
Shunya Uchida
(S)
Takashi Wada
(T)
Hidehiro Yamada
(H)
Kunihiro Yamagata
(K)
Wako Yumura
(W)
Kan Sow Lai
(KS)
Luis Felipe Flores-Suarez
(LF)
Andrea Hinojosa
(A)
Bram Rutgers
(B)
Paul-Peter Tak
(PP)
Rebecca Grainger
(R)
Vicki Quincey
(V)
Lisa Stamp
(L)
Ravi Suppiah
(R)
Emilio Besada
(E)
Andreas Diamantopoulos
(A)
Jan Sznajd
(J)
Elsa Azevedo
(E)
Ruth Geraldes
(R)
Miguel Rodrigues
(M)
Ernestina Santos
(E)
Yeong-Wook Song
(YW)
Sergey Moiseev
(S)
Alojzija Hocˇevar
(A)
Maria Cinta Cid
(MC)
Xavier Solanich Moreno
(XS)
Inoshi Atukorala
(I)
Ewa Berglin
(E)
Aladdin Mohammed
(A)
Mårten Segelmark
(M)
Thomas Daikeler
(T)
Haner Direskeneli
(H)
Gulen Hatemi
(G)
Sevil Kamali
(S)
Ömer Karadag
(Ö)
Seval Pehlevan
(S)
Matthew Adler
(M)
Neil Basu
(N)
Iain Bruce
(I)
Kuntal Chakravarty
(K)
Bhaskar Dasgupta
(B)
Oliver Flossmann
(O)
Nagui Gendi
(N)
Alaa Hassan
(A)
Rachel Hoyles
(R)
David Jayne
(D)
Colin Jones
(C)
Rainer Klocke
(R)
Peter Lanyon
(P)
Cathy Laversuch
(C)
Raashid Luqmani
(R)
Joanna Robson
(J)
Malgorzata Magliano
(M)
Justin Mason
(J)
Win Win Maw
(WW)
Iain McInnes
(I)
John Mclaren
(J)
Matthew Morgan
(M)
Ann Morgan
(A)
Chetan Mukhtyar
(C)
Edmond O'Riordan
(E)
Sanjeev Patel
(S)
Adrian Peall
(A)
Joanna Robson
(J)
Srinivasan Venkatachalam
(S)
Erin Vermaak
(E)
Ajit Menon
(A)
Richard Watts
(R)
Chee-Seng Yee
(CS)
Daniel Albert
(D)
Leonard Calabrese
(L)
Sharon Chung
(S)
Lindsy Forbess
(L)
Angelo Gaffo
(A)
Ora Gewurz-Singer
(O)
Peter Grayson
(P)
Kimberly Liang
(K)
Eric Matteson
(E)
Peter A Merkel
(PA)
Jason Springer
(J)
Antoine Sreih
(A)
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
© 2022 American College of Rheumatology.
Références
Kussmaul A, Maier R. Ueber eine bisher nicht beschriebene eigenthumliche Arterienerkrankung (Periarteritis nodosa), die mit Morbus Brightti und rapid fortschreitender allgemeiner Muskellahmung einhergeht. Dtsch Arch Klin Med 1866;1:484-518.
Davson J, Ball J, Platt R. The kidney in periarteritis nodosa. Q J Med 1948;17:175-202.
Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990:33:1088-93.
Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, et al. American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2012;64:475-87.
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569-81.
Rao JK, Allen NB, Pincus T. Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis. Ann Intern Med 1998;129:345-52.
De Groot K, Harper L, Jayne DR, Flores Suarez LF, Gregorini G, Gross W L, et al. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med 2009;150:670-80.
De Groot K, Rasmussen N, Bacon PA, Tervaert JW, Feighery C, Gregorini G, et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005;52:2461-9.
Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniene J, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003;349:36-44.
Jayne DR, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 2007;18:2180-8.
Watts RA, Lane SE, Scott DG, Koldingsnes W, Nossent H, Gonzalez-Gay MA, et al. Epidemiology of vasculitis in Europe. Ann Rheum Dis 2001;60:1156-7.
Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007;66:222-7.